Drossapharm Competitors and Similar CompaniesClear all

Drossapharm's competitors and similar companies include Apotex, Dexa Group, Sumitomo Pharma and Luoxin Pharmaceuticals Group.

	Drossapharm Drossapharm is a pharmaceutical company.	Apotex Apotex is a company that develops and manufactures pharmaceutical products.	Dexa Group Dexa Group is a provider of pharmaceutical products.	Sumitomo Pharma Sumitomo Pharma (住友ファーマ株式会社) is a company that manufactures and sells pharmaceuticals, veterinary medicines, and food additives.	Luoxin Pharmaceuticals Group Luoxin Pharmaceuticals Group (罗欣药业集团) is a company that produces and trades drugs.
Founding Date	Founding Date 1976	Founding Date 1974	Founding Date 1969	Founding Date 1897	Founding Date 2006
Type	Type Private	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma	Tags Healthcare drug development pharma
Locations	Locations Arlesheim, CH HQ Basel, CH	Locations Toronto, CA HQ Toronto, CA	Locations ID HQ	Locations Osaka, JP HQ Jiangsu, CN Shanghai, CN Fukuoka, JP Hiroshima, JP Hyogo, JP Kobe, JP see more	Locations Linyi, CN HQ
Employees	Employees 681% increase	Employees 6,294	Employees 5,1101% increase	Employees 4,980	Employees 3,388
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 1.4 b	Valuation ($) 693.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥453.3b (FY, 2026)	Revenue (est.) ¥2.2b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥175.6b (FY, 2026)	Cost of goods ¥1.1b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ¥333.5b (FY, 2026)	Gross profit ¥1.1b (FY, 2025)
Net income	Net income N/A	Net income N/A	Net income N/A	Net income ¥106.9b (FY, 2026)	Net income (¥284.5m) (FY, 2025)